151 related articles for article (PubMed ID: 24952432)
1. A polymorphism in JMJD2C alters the cleavage by caspase-3 and the prognosis of human breast cancer.
Hong Q; Yu S; Yang Y; Liu G; Shao Z
Oncotarget; 2014 Jul; 5(13):4779-87. PubMed ID: 24952432
[TBL] [Abstract][Full Text] [Related]
2. Histone demethylase JMJD2C is a coactivator for hypoxia-inducible factor 1 that is required for breast cancer progression.
Luo W; Chang R; Zhong J; Pandey A; Semenza GL
Proc Natl Acad Sci U S A; 2012 Dec; 109(49):E3367-76. PubMed ID: 23129632
[TBL] [Abstract][Full Text] [Related]
3. Cooperative demethylation by JMJD2C and LSD1 promotes androgen receptor-dependent gene expression.
Wissmann M; Yin N; Müller JM; Greschik H; Fodor BD; Jenuwein T; Vogler C; Schneider R; Günther T; Buettner R; Metzger E; Schüle R
Nat Cell Biol; 2007 Mar; 9(3):347-53. PubMed ID: 17277772
[TBL] [Abstract][Full Text] [Related]
4. Jmjd2c histone demethylase enhances the expression of Mdm2 oncogene.
Ishimura A; Terashima M; Kimura H; Akagi K; Suzuki Y; Sugano S; Suzuki T
Biochem Biophys Res Commun; 2009 Nov; 389(2):366-71. PubMed ID: 19732750
[TBL] [Abstract][Full Text] [Related]
5. The demethylase JMJD2C localizes to H3K4me3-positive transcription start sites and is dispensable for embryonic development.
Pedersen MT; Agger K; Laugesen A; Johansen JV; Cloos PA; Christensen J; Helin K
Mol Cell Biol; 2014 Mar; 34(6):1031-45. PubMed ID: 24396064
[TBL] [Abstract][Full Text] [Related]
6. Jumonji domain containing 2C promotes cell migration and invasion through modulating CUL4A expression in lung cancer.
Li N; Jiang D
Biomed Pharmacother; 2017 May; 89():305-315. PubMed ID: 28236704
[TBL] [Abstract][Full Text] [Related]
7. Histone demethylase JMJD2B and JMJD2C induce fibroblast growth factor 2: mediated tumorigenesis of osteosarcoma.
Li X; Dong S
Med Oncol; 2015 Mar; 32(3):53. PubMed ID: 25636512
[TBL] [Abstract][Full Text] [Related]
8. microRNA-216b enhances cisplatin-induced apoptosis in osteosarcoma MG63 and SaOS-2 cells by binding to JMJD2C and regulating the HIF1α/HES1 signaling axis.
Yang D; Xu T; Fan L; Liu K; Li G
J Exp Clin Cancer Res; 2020 Sep; 39(1):201. PubMed ID: 32972441
[TBL] [Abstract][Full Text] [Related]
9. Histone demethylase JMJD2C: epigenetic regulators in tumors.
Zhang C; Wang Z; Ji Q; Li Q
Oncotarget; 2017 Oct; 8(53):91723-91733. PubMed ID: 29207681
[TBL] [Abstract][Full Text] [Related]
10. High-throughput TR-FRET assays for identifying inhibitors of LSD1 and JMJD2C histone lysine demethylases.
Yu V; Fisch T; Long AM; Tang J; Lee JH; Hierl M; Chen H; Yakowec P; Schwandner R; Emkey R
J Biomol Screen; 2012 Jan; 17(1):27-38. PubMed ID: 21859682
[TBL] [Abstract][Full Text] [Related]
11. Targeting the Senescence-Overriding Cooperative Activity of Structurally Unrelated H3K9 Demethylases in Melanoma.
Yu Y; Schleich K; Yue B; Ji S; Lohneis P; Kemper K; Silvis MR; Qutob N; van Rooijen E; Werner-Klein M; Li L; Dhawan D; Meierjohann S; Reimann M; Elkahloun A; Treitschke S; Dörken B; Speck C; Mallette FA; Zon LI; Holmen SL; Peeper DS; Samuels Y; Schmitt CA; Lee S
Cancer Cell; 2018 Feb; 33(2):322-336.e8. PubMed ID: 29438700
[TBL] [Abstract][Full Text] [Related]
12. Hairless is a histone H3K9 demethylase.
Liu L; Kim H; Casta A; Kobayashi Y; Shapiro LS; Christiano AM
FASEB J; 2014 Apr; 28(4):1534-42. PubMed ID: 24334705
[TBL] [Abstract][Full Text] [Related]
13. Proteomic changes induced by histone demethylase JMJD3 in TNF alpha-treated human monocytic (THP-1) cells.
Das A; Das ND; Jung KH; Park JH; Lee HT; Han D; Choi MR; Kang SC; Chai YG
Mol Immunol; 2013 Nov; 56(1-2):113-22. PubMed ID: 23711388
[TBL] [Abstract][Full Text] [Related]
14. Jmjd1a and Jmjd2c histone H3 Lys 9 demethylases regulate self-renewal in embryonic stem cells.
Loh YH; Zhang W; Chen X; George J; Ng HH
Genes Dev; 2007 Oct; 21(20):2545-57. PubMed ID: 17938240
[TBL] [Abstract][Full Text] [Related]
15. Cooperative epigenetic modulation by cancer amplicon genes.
Rui L; Emre NC; Kruhlak MJ; Chung HJ; Steidl C; Slack G; Wright GW; Lenz G; Ngo VN; Shaffer AL; Xu W; Zhao H; Yang Y; Lamy L; Davis RE; Xiao W; Powell J; Maloney D; Thomas CJ; Möller P; Rosenwald A; Ott G; Muller-Hermelink HK; Savage K; Connors JM; Rimsza LM; Campo E; Jaffe ES; Delabie J; Smeland EB; Weisenburger DD; Chan WC; Gascoyne RD; Levens D; Staudt LM
Cancer Cell; 2010 Dec; 18(6):590-605. PubMed ID: 21156283
[TBL] [Abstract][Full Text] [Related]
16. Lysine demethylase KDM3A regulates breast cancer cell invasion and apoptosis by targeting histone and the non-histone protein p53.
Ramadoss S; Guo G; Wang CY
Oncogene; 2017 Jan; 36(1):47-59. PubMed ID: 27270439
[TBL] [Abstract][Full Text] [Related]
17. JMJD2C triggers the growth of multiple myeloma cells via activation of β‑catenin.
Lv M; Liu Q
Oncol Rep; 2021 Mar; 45(3):1162-1170. PubMed ID: 33469678
[TBL] [Abstract][Full Text] [Related]
18. Inositol pyrophosphates regulate JMJD2C-dependent histone demethylation.
Burton A; Azevedo C; Andreassi C; Riccio A; Saiardi A
Proc Natl Acad Sci U S A; 2013 Nov; 110(47):18970-5. PubMed ID: 24191012
[TBL] [Abstract][Full Text] [Related]
19. Jumonji domain-containing protein 2B silencing induces DNA damage response via STAT3 pathway in colorectal cancer.
Chen L; Fu L; Kong X; Xu J; Wang Z; Ma X; Akiyama Y; Chen Y; Fang J
Br J Cancer; 2014 Feb; 110(4):1014-26. PubMed ID: 24473398
[TBL] [Abstract][Full Text] [Related]
20. Comparative integromics on JMJD2A, JMJD2B and JMJD2C: preferential expression of JMJD2C in undifferentiated ES cells.
Katoh Y; Katoh M
Int J Mol Med; 2007 Aug; 20(2):269-73. PubMed ID: 17611647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
